Has Philip Dombrowski, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,032 in general payments to Philip Dombrowski, MD across 64 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Philip Dombrowski, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Philip Dombrowski, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Philip Dombrowski, MD

Vascular & Interventional Radiology · Hyannis, MANPI 1679672794

Payments from drug & device makers

What this record shows

This record is dominated by other: $7,500 of the $10,032 with a category attached, or 74.8%. Angiodynamics, Inc. accounts for 74.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $7,663 and has fallen 94.9% since, to $394 in 2025.

$10,032in general payments, 2019–2025

Across 64 payments — averaging $156.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Angiodynamics, Inc.$8K
Silk Road Medical, Inc.$1K
Stryker$379
Boston Scientific$201
Inari Medical, Inc.$149
Medtronic$140
plus $414 from 7 others

$2,325in research payments, 2019–2025

Across 2 payments — averaging $1162.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bard Peripheral Vascular, Inc.$2K

What the payments were for

Travel & lodging$1,12711%
Food & beverage$1,40514%
Other$7,50075%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Angiodynamics, Inc.	1	$7,500
Silk Road Medical, Inc.	24	$1,249
Stryker	6	$379
Boston Scientific	17	$201
Inari Medical, Inc.	4	$149
Medtronic	3	$140
Veryan Medical Incorporated	2	$123
Cook Medical LLC	2	$104
Intact Vascular, Inc.	1	$98
Endologix LLC	1	$38
Abbott	1	$19
E.r. Squibb & Sons, L.L.C.	1	$16
EKOS Corporation	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Auryon Laser System 100-120 Vac$7,500
ENROUTE Transcarotid Neuroprotection System$1,068
ENROUTE Transcarotid Stent$1,068
ENROUTE .014 Guidewire$946
ENHANCE Transcarotid Peripheral Access Kit$946
FlowTriever$270

How this compares

$10,032 in reported general payments places this provider in the 75th percentile of 89 vascular & interventional radiology providers in Massachusetts.

See all vascular & interventional radiology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$473,481

Medicare patients

507

Services billed

5,152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XareltoRivaroxaban	12	$14,331
ClopidogrelClopidogrel Bisulfate	30	$436

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Hyannis

Suvranu GanguliBoston$878K
Ronald ArellanoBoston$559K
Neil ResnickWorcester$220K
Dania DayeFramingham$103K
Yan EpelboymBoston$83K
Dimitry RabkinBoston$65K
Sidney Kahn IvSpringfield$55K
Ammar SarwarBoston$53K
Neil PatelBurlington$46K
Muneeb AhmedBoston$45K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →